SARS-CoV-2 Spike RBD Antibody [2355] | 10-060

SARS-CoV-2 Spike RBD Antibody [2355] | 10-060 | Gentaur UK, US & Europe Distribution

Host: N/A

Reactivity: Virus

Homology: N/A

Immunogen: Sequenced from human survivors of COVID-19 (SARS-CoV-2) . These are made recombinantly in HEK293 cells. The spike RBD is expressed on the surface of SARS-CoV-2.

Research Area: Infectious Disease, COVID-19

Tested Application: E

Application: ELISA (Quality Tested by ProSci)

Specificiy: Anti-SARS-CoV-2 Spike RBD, clone 2355, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD) . This antibody does not cross-react with the N-terminal domain (NTD) of the spike protein or the RBD of SARS-CoV.

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: >95% by SDS Page

Clonality: Recombinant Monoclonal

Clone: 2355

Isotype: Human IgG1

Conjugate: Unconjugated

Physical State: Liquid

Buffer: This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added.

Concentration: >1.0 mg/ml

Storage Condition: Functional grade preclinical antibodies may be stored sterile as received at 2-8˚ C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80˚ C. Avoid Repeated Freeze Thaw Cycles.

Alternate Name: SARS-CoV-2 Spike RBD Antibody, Receptor Binding Domain Antibody

User Note: N/A

BACKGROUND: N/A